1132054

Mylan Pharmaceuticals Inc. — FEI 3007886374

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 22, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Carlos, CA (United States)